FutraMed Inc. was founded in the state of Utah in the United States to create and apply technology to provide affordable solutions for all individuals suffering from pain, substance abuse, and other physical and behavioral limitations..
With the consumption of painkillers soaring in the United States and throughout the world, FutraMed has developed a patented medical device that has clinical benefits which include reducing opioid consumption and dependence in the treatment of chronic pain.
The technology for the device, a transcutaneous electrical cranial stimulator, is based on the work of Dr. Aimé Limoge of Paris, France and the Limoge Current which he developed. The Limoge Current creates an analgesic effect and potentiates or enhances the treatment drug being used by the chronic pain patient. In collaboration with Dr. Limoge and his associates, the FutraMed team was able to effectively replicate the Limoge Current and create a device that is simple to use, low cost, battery powered, meets regulatory requirements, and is easy to manufacture.
The device is going through the final stages of regulatory approvals necessary to receive the CE mark in order to begin selling in Europe.
U.S. Patent Approved